等待开盘 08-30 09:30:00 美东时间
+0.135
+0.44%
Ashland Inc. declared a $0.415 per share quarterly cash dividend, payable on September 15, 2025, to shareholders of record as of September 1, 2025. As of July 31, 2025, there were 45,709,431 shares outstanding.
08-08 21:01
Analysts' ratings for Axalta Coating Systems (NYSE:AXTA) over the last quarter ...
08-02 02:02
RBC Capital analyst Arun Viswanathan maintains Axalta Coating Systems (NYSE:AXTA) with a Outperform and lowers the price target from $37 to $34.
08-01 23:21
Axalta Coating Systems Shares Down 2% Premarket After BMO Cuts to Market Perfor...
07-16 19:00
Mizuho analyst John Roberts maintains Axalta Coating Systems (NYSE:AXTA) with a Outperform and lowers the price target from $39 to $35.
07-15 21:26
<p>Axalta Coating Systems will release its second quarter 2025 financial results on July 30, 2025, at 6 a.m. ET, available on its Investor Relations site. A conference call at 8 a.m. ET on the same day will feature CEO Chris Villavarayan and CFO Carl Anderson reviewing the financial performance. A live webcast will be available with a replay accessible through July 30, 2026. For phone participation, dial 1-800-225-9448 with conference ID AXALTA. ...
07-08 16:30
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners:维持再鼎医药(ZLAB)"跑赢大市"评级,目标价从73美元升至75美元</p> <p>• 美银证券:维持BioCryst Pharma(BCRX)"买入"评级,目标价从13美元升至15美元
07-02 09:54
Wells Fargo analyst Michael Sison maintains Axalta Coating Systems (NYSE:AXTA) with a Overweight and lowers the price target from $40 to $39.
07-01 22:28
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1140565699993591809.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 丰业银行:维持乌龙制药(URGN)"跑赢大市"评级,目标价从23美元升至47美元</p> <p>• Guggenheim:维持ADC Therapeutics(ADCT)"买入"评级,目标价从7美元升至10美元</p>
06-16 08:40
In the preceding three months, 10 analysts have released ratings for Axalta Coa...
06-13 21:00